Pneumomediastinum secondary prevention

	Pneumomediastinum Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Pneumomediastinum from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Case Studies
Case #1
Pneumomediastinum secondary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Pneumomediastinum secondary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Pneumomediastinum secondary prevention
CDC on Pneumomediastinum secondary prevention
Pneumomediastinum secondary prevention in the news
Blogs on Pneumomediastinum secondary prevention
Directions to Hospitals Treating Pneumomediastinum
Risk calculators and risk factors for Pneumomediastinum secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

In case of spontaneous pneumomediastinum without any complications, patients are required to be hospitalized for 24 hours for observational purposes.
Regular follow-ups are required to avoid recurrence or development of malignant pneumomediastinum.
Quit tobacco smoking.
Quit recreational drug use.
Keep medical condition, which may progress to pneumomediastinum, under control with proper medical therapy.